NCT02761928

Brief Summary

Observational study of axial spine pain and hyperflexibility. Patients will receive physical exam maneuvers (traditional straight leg raise, FABER, facet loading as well as Beighton's hypermobility score) and blood / urine / saliva collection. They will also be separated into pain groups based on their response to injections. A correlation between exam findings and procedure group will be measured.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 4, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

November 12, 2020

Status Verified

November 1, 2020

Enrollment Period

1.6 years

First QC Date

April 24, 2016

Last Update Submit

November 9, 2020

Conditions

Keywords

Facet JointSacroiliac JointMyofascial Trigger Point PainInjectables

Outcome Measures

Primary Outcomes (1)

  • Beighton hypermobility score

    9 point standardized scale

    Prior to injection (2 weeks prior to injection for each patient)

Study Arms (10)

Epidural

Positive response (\>50% pain relief) to any epidural (e.g. interlaminar/paramedian, transforaminal, caudal)

Other: Beighton score for hypermobility

Selective nerve root block

Positive response (\>50% pain relief) to selective nerve root block

Other: Beighton score for hypermobility

Facet injection

Positive response (\>50% pain relief) to intra-articular facet injection

Other: Beighton score for hypermobility

Medial branch block

Positive response (\>50% pain relief) to median branch nerve block

Other: Beighton score for hypermobility

Medial branch RFA

Positive response (\>50% pain relief) to median branch nerve radiofrequency ablation

Other: Beighton score for hypermobility

SIJ injection

Positive response (\>50% pain relief) to sacroiliac joint injection

Other: Beighton score for hypermobility

Lateral branch block

Positive response (\>50% pain relief) to lateral branch nerve block for SIJ

Other: Beighton score for hypermobility

Greater trochanter injection

Positive response (\>50% pain relief) to greater trochanteric bursa injection

Other: Beighton score for hypermobility

Piriformis injection

Positive response (\>50% pain relief) to piriformis injection

Other: Beighton score for hypermobility

Trigger point injection

Positive response (\>50% pain relief) to trigger point injection

Other: Beighton score for hypermobility

Interventions

The beighton score is a 9 point score of flexibility, used for patients with disorders of collagen.

EpiduralFacet injectionGreater trochanter injectionLateral branch blockMedial branch RFAMedial branch blockPiriformis injectionSIJ injectionSelective nerve root blockTrigger point injection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with low back pain who are determined to be candidates for a pain procedure

You may qualify if:

  • Clinical diagnosis of axial back pain (neck, mid-back, lower back) or pain radiating to the extremity, with suspected diagnosis of a specific pain generator amenable to a pain procedure, including disorders of the nerves, joints, and muscles as listed immediately below.
  • Clinical decision to schedule patient for a pain procedure, including procedures targeting the following disorders:
  • Facet arthropathy: intra-articular facet joint injection, medial branch block, medial branch radiofrequency ablation
  • Sacroiliac joint dysfunction: sacroiliac joint injection, lateral branch block, lateral branch radiofrequency ablation
  • Myofascial pain syndrome: trigger point injection
  • Radiculopathy, spinal stenosis, or herniated nucleus pulposus: epidural steroid injection, selective nerve root block
  • Piriformis syndrome: piriformis injection
  • Greater trochanteric bursitis: greater trochanteric bursa injection
  • Able to provide HIPAA authorization to share prior medical records/imaging.

You may not qualify if:

  • Previous diagnosis of cancer.
  • Currently pregnant.
  • Previously enrolled for the same procedure or the same pain generator site. (For example, this would exclude a patient who had an intra-articular facet joint injection at the right L5/S1 if: 1) he had the same injection 3 months ago and was enrolled at that time, or 2) the patient was already enrolled for a medial branch block at the right L5 and sacral ala, as this targets the same facet joint.)
  • Inability or unwillingness of subject or legal guardian/representative to give informed consent (e.g., ward of the state)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

Related Publications (1)

  • Grahame R. Joint hypermobility syndrome pain. Curr Pain Headache Rep. 2009 Dec;13(6):427-33. doi: 10.1007/s11916-009-0070-5.

    PMID: 19889283BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Blood, urine, saliva

MeSH Terms

Conditions

Low Back PainSpinal StenosisRadiculopathyEhlers-Danlos syndrome type 3Myofascial Pain Syndromes

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal DiseasesBone DiseasesMusculoskeletal DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesMuscular Diseases

Study Officials

  • Mark Burish, MD PhD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 24, 2016

First Posted

May 4, 2016

Study Start

January 1, 2016

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

November 12, 2020

Record last verified: 2020-11

Locations